Demonising Justin Gatlin
13th September 2015
Under the Pakistan Cricket Board’s Anti-Doping Rules (“the Anti-Doping Rules”) PCB conducted in-competition dope testing through an independent collecting agency during the Pakistan Cup 2018 held in Faisalabad. Amongst others, the urine sample of Ahmad Shehzad cricketer was collected on 3rd May 2018.
The sample was forwarded to a WADA-accredited laboratory for analysis which, through its Analytical Report, gave an Adverse Analytical Finding for the presence of a Prohibited Substance. PCB received the Analytical Report on 11th June 2018.
On 12th June 2018 PCB requested Anti Doping Agency of Pakistan to constitute an Independent Review Board and give their finding on whether a valid Therapeutic Use Exemption existed and/or whether there had been a departure from the international standards of testing. This required the Review Panel to examine the lab pack and they thus wrote to the WADA accredited Laboratory requesting the same. The WADA accredited Laboratory submitted the Lab pack to the Review Panel earlier this week.
Upon receipt of the findings from the Review Board today, the PCB has issued and handed over a Notice of Charge to Ahmad Shehzad. He has been given till 18th July 2018 to advise whether he wishes to have his B Sample tested and till 27th July 2018 to respond to the charges leveled in the Notice of Charge. The PCB has also provisionally suspended Ahmad Shehzad pending the outcome of the charges.
• This media release was issued by the Pakistan Cricket Board (PCB) on 10 July 2018. Click here for the original.
The World Anti-Doping Agency (WADA) has been blocked from completing its mission to extract data...
The Rodchenkov Anti-Doping Act (RADA) has been introduced into the US Senate, after being introduced...
Ten athletes have been cleared to represent new countries since the last update from the...